PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Pyxis Oncology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.76+0.08 (+4.76%)
Close on Oct 19, 2026
- Market cap
- $112.63M
- P/E (TTM)
- –
- Dividend yield
- –
Pyxis Oncology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Market Cap | $146.80M | $164.85M |
| Enterprise Value | $113.80M | $87.06M |
| PB Ratio | 12.83 | 2.03 |
| P/TBV Ratio | 12.83 | 2.31 |
Income (trailing twelve months)
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Operating Income | -$92.11M | -$21.44M |
| Net Income | -$88.73M | -$22.46M |
| EBITDA | -$87.92M | -$16.91M |
| EPS (Diluted) | -$1.41 | -$0.83 |
Returns
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -179.1% | -53.1% |
| Return on Assets (ROA) | -99.6% | -41.0% |
| Return on Capital Employed (ROCE) | -335.6% | -37.8% |
Balance sheet
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $33.00M | $62.42M |
| Net Cash (Debt) | $33.00M | $15.68M |
| Net Cash Per Share | $0.40 | $0.66 |
| Equity (Book Value) | $11.44M | $48.79M |
| Book Value Per Share | $0.14 | $1.36 |
| Tangible Book Value | $11.44M | $23.06M |
| Working Capital | $9.26M | $75.77M |
Financial position
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Current Ratio | 1.34 | 3.30 |
| Quick Ratio | 1.20 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Operating Cash Flow | -$67.91M | -$12.35M |
Efficiency
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Profits Per Employee | -$1.58M | -$703.34K |
| Employee Count | 56 | 74 |
Dividends and yields
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Earnings Yield | -60.4% | -22.7% |
Shares
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Shares Outstanding | 83,408,100 | 58,179,650 |
| Shares Change (YoY) | 3.32% | 11.1% |
| Shares Change (QoQ) | 0.96% | 0.54% |
| Float | 66,417,400 | 49,173,100 |
| Shares Held by Insiders | 20.4% | 11.6% |
| Shares Held by Institutions | 40.9% | 59.4% |
Scores
| Measure | Pyxis Oncology | Industry median |
|---|---|---|
| Altman Z-Score | -15.84 | -0.24 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Pyxis Oncology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.